Introduction
We are dedicated to offering solutions to patients suffering from Tricuspid Regurgitation, a severe and untreated heart valve disease that has long been neglected.
What we do
Our innovation is a minimally invasive approach offering a transcatheter one-step replacement of the diseased enlarged valve. The device conforms to the dilated annulus anatomy with its proprietary atraumatic anchoring structure and modulates the heart valve to its physiological size, resulting in improved health and quality of life.
Our Team
We are an agile and focused organization with broad expertise and experience in heart valves, supported by top tier Key Opinion Leaders. We work relentlessly and passionately on safe and efficient solutions to save and improve the lives of millions of patients.
